Global Medical Lead, Neisseria

**Site Name**: USA - Maryland - Rockville, Belgium-Wavre, GSK HQ
**Posted Date**: Jan 22 2025

Global Medical Lead, Neisseria

**Job Purpose**

The Global Medical Lead (GML) is a key senior business leadership role, reporting to the SVP Global Medical Affairs, Vaccines, is a key member of GSK’s Global Medical Affairs, Vaccines Leadership Team.

The GML will have full responsibility for the Global Medical Strategy for an asset. The GML will lead the translation of our science to shape the practice of medicine and vaccines to deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies.

The role will be accountable for the Medical strategic direction of an Asset and the matrix leadership of the Global Asset Medical Leadership Team, integrating innovative strategies that advance patient care and help shape the practice of medicine. The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/vaccine development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients.

In addition to leading the Global Asset Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Medicines/Vaccines Development Team and the Medicine/Vaccine Commercial Team where he or she will provide Medical insight and expertise to inform and influence evidence generation and scientific communication plans across the lifecycle to optimize patient impact within markets.

A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms.

**Key Responsibilities**
- ** Lead both the cross-functional product medical team (PMT) and product development at the Global level**:

- ** As convenor and chair of the PMT**
- Jointly accountable for developing the global medical brand strategy and plans for a product by convening the PMT
- Set direction along strategic framework of the medical brand plan including setting scientific objectives, own the medical scientific narrative and the integrated communication plan
- Accountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global operations team and Global data team
- Represent medical in cross-functional strategy meetings and workshops, and proactively offer options for innovative medical strategy for the IAP at the PDT and PCT meetings
- Provide focused support at key inflection points during development (e.g., launch)
- ** As Lead cross-functional product medical team (PMT) and medical product team at Global level**
- Responsible for representing the voice of the CPO organisation for the product
- Accountable for all medical activities related to product development at the global level
- Lead, coach, and mentor direct reports that support the PMT in development of medical brand strategy and plans, and execute and/or support execution of global tactics
- Address broader holistic disease area considerations as they arise by convening other relevant PMLs ad-hoc

**Enterprise Leadership**:

- Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation).
- Act as a partner to the MDL and MCL, ensure integrated and thoughtful insights from across a diverse stakeholder set contribute to shaping the medicines vision, development strategy and clinical development in the early phases of development, and for refining medical strategy as clinical evidence is generated.
- Ensure that medical insights from the priority markets are incorporated into the GSMT to inform all evidence, product development, and asset strategy deliverables.
- Accountable for leading the GMST in the development and delivery of the Global medical product strategy and associated global deliverables enabling prioritized LOCs to execute the strategy and deliver positive patient impact locally.
- Ensure that the evidence generation plan aligns to identified unmet needs and prioritized evidence gaps and addresses key medical and market access requirements, maximizing the asset competitiveness from launch through lifecycle management for priority markets

**Performance culture**
- Maintains the patient at the center of everything we do.
- Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key LOCs.
- Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects, and encouraging employees to work with diverse